Duke Inventions Bring $82.6M in Revenue and Launch 6 New Start-Ups
Read More

Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
Read More

Basking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke
Read More

Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma
Read More

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation
Read More

From Interns to Employees: Duke Trainees Find Full-Time Home at OTC
Read More

Carpe, a Duke-founded Startup, Acquired by Topspin Consumer Partners
Read More

New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University
Read More

The Kardashians Take Longevity Test that Reveals Biological Age in 'The Kardashians' Upcoming Season Finale
Read More

PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452

Have Questions?

Please contact us or subscribe for more opportunities